Description
CJC-1295 / Ipamorelin combines two distinct compounds studied for their effects on growth-hormone signaling.
CJC-1295 is a synthetic analog associated with growth-hormone-releasing hormone activity. Ipamorelin belongs to the growth-hormone secretagogue family and acts through a separate receptor system involved in stimulating growth-hormone release. The combination therefore provides a research model involving two different upstream pathways influencing the growth-hormone axis.
Research involving this combination is commonly focused on endocrine signaling, growth-hormone secretion, receptor interactions, and downstream physiology. Because the combination is not itself an FDA-approved drug product, research findings should not be interpreted as establishing a validated clinical protocol.
The product is supplied as 10mg of CJC-1295 and 10mg of Ipamorelin combined of lyophilized material in a 3 mL vial with BAC Water specified as the diluent.
Research Use Only. Not for Human or Veterinary Use. These products are not intended to diagnose, treat, cure, or prevent any disease. Product information is provided for research and educational purposes only.
Reviews
There are no reviews yet.